Health Care [ 6/12 ] | Biotechnology [ 43/73 ]
NYSE | Common Stock
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell programming in the United States.
It operates through Cell Engineering and Biosecurity segments.
The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics and antibody developability Datapoints services, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products.
It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats.
The company serves the pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries.
Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 7, 25 | -1.10 Decreased by -900.00% | -0.10 Decreased by -1.00 K% |
| Jun 13, 25 | -1.68 Decreased by -2.00 K% | -0.08 Decreased by -2.00 K% |
| Feb 25, 25 | -2.00 Decreased by -1.72 K% | -0.06 Decreased by -3.33 K% |
| Nov 11, 24 | -1.08 Decreased by -575.00% | -0.07 Decreased by -1.48 K% |
| Aug 8, 24 | -0.11 Decreased by -22.22% | -0.08 Decreased by -37.50% |
| May 9, 24 | -0.08 Increased by +27.27% | -0.08 |
| Feb 29, 24 | -0.11 Decreased by -22.22% | -0.10 Decreased by -10.00% |
| Nov 8, 23 | -0.16 Increased by +60.98% | -0.09 Decreased by -77.78% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 25 | 49.60 M Decreased by -11.75% | -60.30 M Increased by +72.24% | Decreased by -121.56% Increased by +68.54% |
| Mar 31, 25 | 48.32 M Increased by +27.34% | -90.96 M Increased by +45.18% | Decreased by -188.25% Increased by +56.95% |
| Dec 31, 24 | 43.85 M Increased by +26.16% | -107.53 M Increased by +49.20% | Decreased by -245.25% Increased by +59.74% |
| Sep 30, 24 | 89.05 M Increased by +60.65% | -56.40 M Increased by +81.38% | Decreased by -63.34% Increased by +88.41% |
| Jun 30, 24 | 56.21 M Decreased by -30.24% | -217.18 M Decreased by -25.31% | Decreased by -386.40% Decreased by -79.62% |
| Mar 31, 24 | 37.94 M Decreased by -52.98% | -165.91 M Increased by +19.06% | Decreased by -437.25% Decreased by -72.16% |
| Dec 31, 23 | 34.76 M Decreased by -64.64% | -211.69 M Decreased by -19.91% | Decreased by -609.10% Decreased by -239.10% |
| Sep 30, 23 | 55.43 M Decreased by -16.52% | -302.89 M Increased by +54.80% | Decreased by -546.44% Increased by +45.86% |